Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | MMP1 | P03956 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
| ▸ | MMP3 | P08254 | 1/20 | 0.34 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29691691 | 0.94 | THRB (0.50) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL29691692 | 0.91 | THRB (0.53) | TSHRTHRBCA1ALDH1A1POLB | |
| SCHEMBL8917596 | 0.86 | THRB (0.51) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL1326500 | 0.84 | TSHR (0.57) | TSHRTHRBCA12CA1CA9 | |
| SCHEMBL29174089 | 0.84 | THRB (0.41) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL26908076 | 0.84 | TSHR (0.53) | TSHRTHRBCA12CA1CA9 | |
| SCHEMBL4982835 | 0.83 | TSHR (0.56) | TSHRTHRBCA12CA1CA9 | |
| SCHEMBL18674241 | 0.83 | TSHR (0.65) | TSHRTHRBCA12CA1CA9 | |
| SCHEMBL4346470 | 0.82 | CA12 (0.50) | CA12CA1CA9ALDH1A1MMP1 | |
| Hydrochloric Acid SCHEMBL28209960 | 0.80 | CA12 (0.48) | CA12CA1CA9ALDH1A1MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170088655-A1 | COPOLYMERS CONTAINING PHOSPHORYLCHOLINE GROUPS AND METHODS OF PREPARING AND USING THE SAME | Suntech Co. (KR) | 2017-03-30 | — | — | US | disclosed |
| US-9546229-B2 | Copolymers containing phosphorylcholine groups and methods of preparing and using the same | Suntech Co. (KR) | 2017-01-17 | — | — | US | disclosed |
| EP-2634198-B1 | Copolymers containing phosphorylcholine groups and methods of preparing and using the same | SUNTECH CO LTD (KR) | 2014-09-17 | — | — | EP | disclosed |
| US-20130231400-A1 | Copolymers Containing Phosphorylcholine Groups and Methods of Preparing and Using the Same | DOTTER, INC. (KR) | 2013-09-05 | — | — | US | disclosed |
| EP-2634198-A1 | Copolymers containing phosphorylcholine groups and methods of preparing and using the same | Suntech Co., Ltd. (KR) | 2013-09-04 | — | — | EP | disclosed |
| US-20120164210-A1 | PHOTODYNAMIC THERAPEUTIC AGENT HAVING CELL-SPECIFIC ACTIVE ACCUMULATION PROPERTIES | THE UNIVERSITY OF TOKYO | 2012-06-28 | — | — | US | disclosed |
| EP-2374825-A1 | PHOTODYNAMIC THERAPEUTIC AGENT SHOWING ACCUMULATION OF CELL-SPECIFIC FUNCTIONS | Keio University (JP) | 2011-10-12 | — | — | EP | disclosed |
| EP-0947244-B1 | SOLUBILIZERS, EMULSIFIERS AND DISPERSANTS | NOF CORP (JP) | 2004-12-29 | — | — | EP | disclosed |
| US-6503632-B1 | Siloxane polymers typified by polydimethylsiloxane have excellent biocompatibility, gas permeability, etc. alkylamide groups impart strength; medical equipment | NOF CORPORATION (JP) | 2003-01-07 | — | — | US | disclosed |
| EP-1116740-A1 | POLYDIALKYLSILOXANE / POLYAMIDE COPOLYMER, PROCESS FOR PRODUCING THE SAME, AND VARIOUS MATERIALS | NOF CORPORATION (JP) | 2001-07-18 | — | — | EP | disclosed |
| US-6214957-B1 | POLYMER CONTAINING HYDROPHILIC MONOMERS HAVING AMMONIO ETHYL PHOSPHATE SIDE CHAINS, POLYMER IS SOLUBLE IN SOLVENT CONTAINING WATER | NOF CORPORATION (JP) | 2001-04-10 | — | — | US | disclosed |
| EP-0947244-A1 | SOLUBILIZERS, EMULSIFIERS AND DISPERSANTS | NOF CORPORATION (JP) | 1999-10-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120164210-A1 | PHOTODYNAMIC THERAPEUTIC AGENT HAVING CELL-SPECIFIC ACTIVE ACCUMULATION PROPERTIES | CD47, CD44, EPCAM | TSHR 3669/4885THRB 4219/4885CA12 119/4885 |
| US-20170088655-A1 | COPOLYMERS CONTAINING PHOSPHORYLCHOLINE GROUPS AND METHODS OF PREPARING AND USING THE SAME | PHOSPHO1, PCTP, SGMS1 | TSHR 2627/4885THRB 3491/4885CA12 1353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.